Literature DB >> 12111696

Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts.

Lori Rice1, Von G Samedi, Theresa A Medrano, Carol A Sweeney, Henry V Baker, Anne Stenstrom, Jaime Furman, Kathleen T Shiverick.   

Abstract

BACKGROUND: Isoflavones inhibit the growth of some types of tumor cells, including prostate adenocarcinoma. This study used LNCaP cells and xenografts to investigate the mechanisms of the antiproliferative effects of biochanin A, a major isoflavone present in red clover but not soy-derived products.
METHODS: LNCaP cells were exposed to varying doses of biochanin A to evaluate viability, DNA synthesis, and DNA fragmentation (TUNEL) analysis. Regulation of gene expression was determined by using Western immunoblotting and cDNA microarrays. Anti-tumorigenic effects were evaluated by using athymic mice with LNCaP flank tumors.
RESULTS: Biochanin A induced a dose-dependent inhibition of proliferation and [(3)H]thymidine incorporation that correlated with increased DNA fragmentation, indicative of apoptosis. Western blot analyses of cell cycle regulatory proteins revealed that biochanin A significantly decreased expression of cyclin B and p21, whereas flow cytometry showed that cells were accumulating in the G(0)/G(1) phase. cDNA microarray analyses identified 29 down-regulated genes with six reduced below assay detection limits. Eleven genes were up-regulated, including 9 that were undetectable in controls. In mice with LNCaP xenografts, biochanin A significantly reduced tumor size and incidence.
CONCLUSION: These results indicate that biochanin A inhibits prostate cancer cell growth through induction of cell cycle arrest and apoptosis. Biochanin A-regulated genes suggest multiple pathways of action. Biochanin A inhibits the incidence and growth of LNCaP xenograft tumors in athymic mice. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111696     DOI: 10.1002/pros.10100

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

1.  Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells.

Authors:  Shilpa Puli; Aditi Jain; James C K Lai; Alok Bhushan
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

2.  Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.

Authors:  Lori Rice; Renita Handayani; Yuehua Cui; Theresa Medrano; Von Samedi; Henry Baker; Nancy J Szabo; Charles J Rosser; Steve Goodison; Kathleen T Shiverick
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

3.  Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.

Authors:  Young Jin Moon; Kazuko Sagawa; Kosea Frederick; Shuzhong Zhang; Marilyn E Morris
Journal:  AAPS J       Date:  2006-07-07       Impact factor: 4.009

4.  Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.

Authors:  Mihai D Niculescu; Elena A Pop; Leslie M Fischer; Steven H Zeisel
Journal:  J Nutr Biochem       Date:  2006-09-08       Impact factor: 6.048

5.  Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.

Authors:  Shilpa Puli; James C K Lai; Alok Bhushan
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

6.  Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy.

Authors:  Qiang Dong; Degui Wang; Lanlan Li; Jie Wang; Qiao Li; Lei Duan; Hang Yin; Xiaoqing Wang; Yang Liu; Guoqiang Yuan; Yawen Pan
Journal:  Mol Neurobiol       Date:  2022-01-04       Impact factor: 5.590

7.  Biochanin A inhibits breast cancer tumor growth in a murine xenograft model.

Authors:  Young Jin Moon; Beom Soo Shin; Guohua An; Marilyn E Morris
Journal:  Pharm Res       Date:  2008-05-03       Impact factor: 4.200

8.  Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells.

Authors:  Mohieldin M Youssef; Mai F Tolba; Noha N Badawy; Andrew W Liu; Eman El-Ahwany; Amani E Khalifa; Suher Zada; Ashraf B Abdel-Naim
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

9.  Biochanin A Induces S Phase Arrest and Apoptosis in Lung Cancer Cells.

Authors:  Yan Li; Haiyang Yu; Fengfeng Han; Mengmeng Wang; Yong Luo; Xuejun Guo
Journal:  Biomed Res Int       Date:  2018-10-03       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.